<DOC>
	<DOCNO>NCT02813486</DOCNO>
	<brief_summary>The purpose study evaluate safety GC3111 describe immunogenicity single dose GC3111 versus BoostrixÂ® vaccine among healthy adult 19 &lt; 65 year age .</brief_summary>
	<brief_title>Safety Immunogenicity Study Tetanus , Diphtheria Acellular Pertussis ( Tdap ) Vaccine</brief_title>
	<detailed_description>To evaluate immunogenicity GC3111 tetanus , diphtheria acellular pertussis ( Tdap ) vaccine healthy adult . To evaluate safety ( solicited adverse event ) GC3111 healthy adult .</detailed_description>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 19 64 year time vaccination Informed consent assent form sign dated Known suspect receipt Tdap vaccine Subject pregnant , lactating , child bear potential without use effective method contraception practice abstinence Receipt vaccine within 30 day receive study vaccine Any condition , opinion Investigator , might interfere ability comply trial procedure .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>